Researchers in a new study learned that consuming this specific type of coffee may substantially increase a person’s risk of ...

Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...

Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the ...

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...

These are exciting times for biotech business Complement Therapeutics, which stands on the cusp of an important milestone in ...

随着证据的不断积累，人们对 GLP-1 受体激动剂导致视网膜并发症的担忧日益加剧。在两项主要的心血管试验——SUSTAIN 6 和 PIONEER 6 中，使用司美格鲁肽的患者出现糖尿病视网膜病变并发症的比例高于服用安慰剂的患者。

Older people with diabetes who do not keep blood sugar levels low are three times more likely to develop eye disease compared ...

Alcon AG plans to acquire Lumithera Inc., adding its photobiomodulation (PBM) device designed to treat early and intermediate ...

A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ophthalmology over the past five decades.

Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which ...